Hippocratic AI, a startup that builds AI solutions that can handle non-diagnostic patient tasks, secured a massive $141 million Series B at a $1.64 billion valuation led by Kleiner Perkins, the company announced Thursday. The funding comes nine months after Hippocratic AI raised a $53 million round from General Catalyst and Andreessen Horowitz and five months after it raised $17 million from Nvidia. The onset is less than two years old.
While most AI companies generating healthcare focus on reducing the administrative burden, Hippocrates AI addresses the shortage of healthcare professionals by creating agents that can perform simple tasks such as pre-operative procedures, remote patient monitoring and preparation of the meeting.
In 2024, the startup has signed contracts with 23 health systems and insurers. Hippocrates is using the new capital to expand the product into more markets and internationally.
